Anzeige
Mehr »
Login
Dienstag, 14.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Uran-Rallye: Preise ziehen wieder an - Jetzt nicht den Einstieg verpassen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
20 Leser
Artikel bewerten:
(0)

Instacare Corp. Announces Details of Conference Call on January 27 and to Post Guidance / COMPANY ANTICIPATES POSTING 2010 AND 2011 OUTLOOK REPORT PREPARED BY WILLIAM N. WALLING, CFA ON THE COMPANY'S WEBSITE LATER THIS AFTERNOON

LOS ANGELES, Jan. 25 /PRNewswire-FirstCall/ -- Instacare Corp. (OTC Bulletin Board: ISCR), a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies, today announced the successful completion of the 2010 and 2011 guidance report prepared by William N. Walling, CFA. The Company expects to post this report in its entirety on its website at http://www.instacare.net/ later in the afternoon on January 25, 2010, and management will conduct a conference call with shareholders and the investment community at 2 p.m. ET on January 27, 2010, to discuss this report and answer questions.

To access the call, investors can dial 1-866-227-3320 if dialing from within the United States, or 1-416-849-5927 if dialing internationally. It is recommended that you dial in at least 10 minutes prior to the call. Please reference the Instacare Corp. Conference Call. Following the call, an audio file of the conference call will be posted on http://www.instacare.net/ so those who miss the live call can access the information.

Robert Jagunich Chairman of Instacare commented, "As promised, we will share this important report prepared by William Walling, CFA, providing as much information as possible to our loyal shareholders. We remain excited about the potential for our technology, irrespective of the status of the health care reform legislation currently contemplated by the Federal Government. We are strategically positioned in the sweet spot of the changes within the health care industry, as the key constituents all seek methods for streamlining the collection and management of health care data. We have asked Mr. Willing to provide an outlook both with and without health care reform legislation, and we will be providing this information to investors before discussing it on Wednesday's conference call."

Forward-Looking Statements

This news release contains forward-looking statements about our business, or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions.

For more information about Instacare Corp. and/or its revolutionary MD@Hand cell phone centric technologies, please visit the Instacare web site http://www.instacare.net/ or call the company at (805) 446-2973.

Contact: Keith Berman, Secretary and CFO info@instacare.net 2660 Townsgate Road Suite 300 Westlake Village, CA 91361 Ph : 805-446-1973 Fax: 805-446-1983

instaCare Corp.

CONTACT: Keith Berman, Secretary and CFO of instaCare Corp.,
+1-805-446-1973, fax, +1-805-446-1983, info@instacare.net

Web Site: http://www.instacare.net/

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.